Blog

EXPLORE LATEST INSIGHTS

Featured post

Webinar: Optimizing the Secretory Pathway – High-Throughput Protein Engineering for Therapeutic Manufacturing

Join our webinar on March 3 to discover how to optimize the secretory pathway for next-gen biologics manufacturing.

Read more
Webinar: Optimizing the Secretory Pathway – High-Throughput Protein Engineering for Therapeutic Manufacturing

News

PRESS RELEASE

January 12, 2026

Avenue Biosciences raises $5.7M to scale the first platform modulating the secretory pathway for enhanced therapeutic protein manufacturing

Read more
Avenue Biosciences raises $5.7M to scale the first platform modulating the secretory pathway for enhanced therapeutic protein manufacturing

June 11, 2025

Avenue Biosciences Selected for 2025 BioTools Innovator Accelerator Program

Read more
Avenue Biosciences Selected for 2025 BioTools Innovator Accelerator Program

May 20, 2025

Veli-Pekka Jaakola joins Avenue Biosciences as Chief Technology Officer

Read more
Veli-Pekka Jaakola joins Avenue Biosciences as Chief Technology Officer

October 22, 2024

Avenue Biosciences Raises $2.5M Seed to Scale AI-Enhanced Protein Engineering

Read more
Avenue Biosciences Raises $2.5M Seed to Scale AI-Enhanced Protein Engineering

October 7, 2024

Avenue Biosciences Welcomes Industry Experts to Advisory Board for Market Insights and Focused Growth

Read more
Avenue Biosciences Welcomes Industry Experts to Advisory Board for Market Insights and Focused Growth

October 4, 2024

Avenue Biosciences Joins StartX, the Largest Community of Stanford Founders

Read more
Avenue Biosciences Joins StartX, the Largest Community of Stanford Founders

LATEST RESOURCES

Filter by
Reset
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Webinar
Published on 
February 6, 2026
By 
All
webinar main image

Webinar: Optimizing the Secretory Pathway – High-Throughput Protein Engineering for Therapeutic Manufacturing

Join our webinar on March 3 to discover how to optimize the secretory pathway for next-gen biologics manufacturing.

Webinar: Optimizing the Secretory Pathway – High-Throughput Protein Engineering for Therapeutic Manufacturing
Blog post
Published on 
September 3, 2025
By 
All

Signal peptides in biosimilar development: Small sequences, big impact

With over 200 biosimilars approved globally (1) and many top-selling biologics losing exclusivity in the next five years, the demand for cost-efficient, large-scale production of recombinant antibody therapeutics is growing.

Signal peptides in biosimilar development: Small sequences, big impact
Blog post
Published on 
July 4, 2025
By 
All

Reviewing real-life success stories: How signal peptide engineering can boost mRNA therapy development

Strong evidence exists for applying signal peptide engineering to design more efficient vaccines for various infectious viral diseases, including Ebola virus, SARS-Cov-2, and Zika virus.

Reviewing real-life success stories: How signal peptide engineering can boost mRNA therapy development
Blog post
Published on 
June 6, 2025
By 
All
Abstract continuous innovation

The virus innovates – why aren’t we? Rethinking signal peptides in biologics development

While viruses tirelessly reinvent themselves to optimize infection and immune evasion, including refining their signal peptides to optimize viral replication in the secretory pathway, the ability to engineer viral signal peptides for biotechnology tends to remain limited.

The virus innovates – why aren’t we? Rethinking signal peptides in biologics development
Blog post
Published on 
May 12, 2025
By 
All

Understanding signal peptides: Small expression elements and their therapeutic implications

This blog sheds light on the significant role of signal peptides in protein synthesis and therapy development.

Understanding signal peptides: Small expression elements and their therapeutic implications
Blog post
Published on 
April 8, 2025
By 
All
Abstract of AI designed proteins

Using signal peptides to enhance expression of de novo-designed proteins

In this blog, we examine how signal peptide engineering can address challenges in the expression of de novo-designed proteins.

Using signal peptides to enhance expression of de novo-designed proteins